Cited by 180Amyotrophic Lateral Sclerosis ResearchEpigenetics and DNA MethylationGenetic Neurodegenerative Diseases

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD

Open access

Liu, Elaine Y., Russ, Jenny, Wu, Kathryn, Neal, Donald, Suh, Eunran, McNally, Anna G., Irwin, David J., Van Deerlin, Vivianna M., Lee, Edward B.·2014·Acta Neuropathologica

DOI 10.1007/s00401-014-1286-yPMC PMC4161616

Open this paper in CoChat — free account

Abstract

Hexanucleotide repeat expansions of C9orf72 are the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal degeneration. The mutation is associated with reduced C9orf72 expression and the accumulation of potentially toxic RNA and protein aggregates. CpG methylation is known to protect the genome against unstable DNA elements and to stably silence inappropriate gene expression. Using bisulfite cloning and restriction enzyme-based methylation assays on DNA from human brain and peripheral blood, we observed CpG hypermethylation involving the C9orf72 promoter in cis to the repeat expansion mutation in approximately one-third of C9orf72 repeat expansion mutation carriers. Promoter hypermethylation of mutant C9orf72 was associated with transcriptional silencing of C9orf72 in patient-derived lymphoblast cell lines, resulting in reduced accumulation of intronic C9orf72 RNA and reduced numbers of RNA foci. Furthermore, demethylation of mutant C9orf72 with 5-aza-deoxycytidine resulted in increased vulnerability of mutant cells to oxidative and autophagic stress. Promoter hypermethylation of repeat expansion carriers was also associated with reduced accumulation of RNA foci and dipeptide repeat protein aggregates in human brains. These results indicate that C9orf72 promoter hypermethylation prevents downstream molecular aberrations associated with the hexanucleotide repeat expansion, suggesting that epigenetic silencing of the mutant C9orf72 allele may represent a protective counter-regulatory response to hexanucleotide repeat expansion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00401-014-1286-y

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 6×
“Both processes have been implicated in AlS and FTD [36, 37].”
Influential
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Broeckhoven, C. V., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,248
Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,127
C9orf72 nucleotide repeat structures initiate molecular cascades of disease
Haeusler, A. R., Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M.-S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., et al. (2014) · Nature · doi:10.1038/nature13124 · Cited by 978
Stress granules as crucibles of ALS pathogenesis
Li, Y. R., King, O. D., Shorter, J., & Gitler, A. D. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201302044 · Cited by 948
Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W., Urbinati, C. R., Teng‐umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., & Swanson, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Repeat instability: mechanisms of dynamic mutations
Pearson, C. E., Edamura, K. N., & Cleary, J. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1689 · Cited by 924 · cited 1×
“rANT aggregates have been proposed to be toxic [2, 46], perhaps through disruption of cellular pathways like autophagy or altered proteostasis [9, 50].”
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877

Show all 68 references

Sorted by citations

Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Rinaldi, C., & Wood, M. J. A. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.148 · Cited by 788
C9orf72-mediated ALS and FTD: multiple pathways to disease
Balendra, R., & Isaacs, A. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0047-2 · Cited by 715
Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons
Shi, Y., Lin, S., Staats, K. A., Li, Y., Chang, W.-H., Hung, S.-T., Hendricks, E., Linares, G. R., Wang, Y., Son, E. Y., et al. (2018) · Nature Medicine · doi:10.1038/nm.4490 · Cited by 566
Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs
Jiang, J., Zhu, Q., Gendron, T. F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J. E., Jafar-nejad, P., Drenner, K., Schulte, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.006 · Cited by 536
Molecular mechanisms underlying nucleotide repeat expansion disorders
Malik, I., Kelley, C. P., Wang, E. T., & Todd, P. K. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00382-6 · Cited by 363
The frontotemporal dementia-motor neuron disease continuum
Burrell, J. R., Halliday, G. M., Kril, J. J., Ittner, L. M., Götz, J., Kiernan, M. C., & Hodges, J. R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00737-6 · Cited by 384
Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress
Zhang, Y., Jansen‐West, K. R., Xu, Y.-F., Gendron, T. F., Bieniek, K. F., Lin, W.-L., Sasaguri, H., Caulfield, T. R., Hubbard, J., Daughrity, L. M., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1336-5 · Cited by 346
C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins
Zhang, Y., Gendron, T. F., Grima, J. C., Sasaguri, H., Jansen‐West, K. R., Xu, Y.-F., Katzman, R. B., Gass, J. M., Murray, M. E., Shinohara, M., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4272 · Cited by 324
Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease
Pottier, C., Bieniek, K. F., Finch, N., van de Vorst, M., Baker, M., Perkersen, R., Brown, P., Ravenscroft, T., van Blitterswijk, M., Nicholson, A. M., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1436-x · Cited by 312
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
Irwin, D. J., Cairns, N. J., Grossman, M., McMillan, C. T., Lee, E. B., Deerlin, V. M. V., Lee, V. M. ‐., & Trojanowski, J. Q. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1380-1 · Cited by 278
Self-citation
The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter
on behalf of the BELNEU CONSORTIUM, Gijselinck, I., Van Mossevelde, S., van der Zee, J., Sieben, A., Engelborghs, S., De Bleecker, J., Ivanoiu, A., Deryck, O., Edbauer, D., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.159 · Cited by 242
Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72
Zhu, Q., Jiang, J., Gendron, T. F., McAlonis-Downes, M., Jiang, L., Taylor, A., Diaz Garcia, S., Ghosh Dastidar, S., Rodriguez, M. J., King, P., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0619-5 · Cited by 220
Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers
Mackenzie, I. R. A., Frick, P., Grässer, F. A., Gendron, T. F., Petrucelli, L., Cashman, N. R., Edbauer, D., Kremmer, E., Prudlo, J., Troost, D., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1476-2 · Cited by 231
C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis
Rohrer, J. D., Isaacs, A. M., Mizielinska, S., Mead, S., Lashley, T., Wray, S., Sidle, K. C. L., Fratta, P., Orrell, R. W., Hardy, J., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70233-9 · Cited by 255
R Loops and Links to Human Disease
Richard, P., & Manley, J. L. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.031 · Cited by 230
Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era
Paez-Colasante, X., Figueroa‐Romero, C., Sakowski, S. A., Goutman, S. A., & Feldman, E. L. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.57 · Cited by 227
The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease
Haeusler, A. R., Donnelly, C. J., & Rothstein, J. D. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.38 · Cited by 205
Loss of C9orf72 Enhances Autophagic Activity via Deregulated mTOR and TFEB Signaling
Ugolino, J., Ji, Y. J., Conchina, K., Chu, J., Nirujogi, R. S., Pandey, A., Brady, N. R., Hamacher-Brady, A., & Wang, J. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006443 · Cited by 185
ALS: A bucket of genes, environment, metabolism and unknown ingredients
Zufiría, M., Gil-Bea, F. J., Fernández‐Torrón, R., Poza, J. J., Muñoz-Blanco, J. L., Rojas‐García, R., Riancho, J., & de Munaín, A. L. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.004 · Cited by 204
Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing
Schludi, M. H., Bavarian Brain Banking Alliance, May, S., Grässer, F. A., Rentzsch, K., Kremmer, E., Küpper, C., Klopstock, T., Arzberger, T., & Edbauer, D. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1450-z · Cited by 195
Familial Amyotrophic Lateral Sclerosis
Boylan, K. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.001 · Cited by 193
C9ORF72: What It Is, What It Does, and Why It Matters
Smeyers, J., Banchi, E.-G., & Latouche, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661447 · Cited by 198
There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS
Gitler, A. D., & Tsuiji, H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.004 · Cited by 155
G-Quadruplexes as pathogenic drivers in neurodegenerative disorders
Wang, E., Thombre, R., Shah, Y., Latanich, R., & Wang, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab164 · Cited by 152
RNA metabolism in neurodegenerative disease
Liu, E. Y., Cali, C. P., & Lee, E. B. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028613 · Cited by 138
Self-citation
Isoform‐specific antibodies reveal distinct subcellular localizations of C 9orf72 in amyotrophic lateral sclerosis
Xiao, S., MacNair, L., McGoldrick, P., McKeever, P. M., McLean, J. R., Zhang, M., Keith, J. L., Zinman, L. H., Rogaeva, E. A., & Robertson, J. (2015) · Annals of Neurology · doi:10.1002/ana.24469 · Cited by 154
The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients
Xi, Z., Zhang, M., Bruni, A. C., Maletta, R., Colao, R., Fratta, P., Polke, J. M., Sweeney, M. G., Mudanohwo, E. E., Nacmias, B., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1401-8 · Cited by 143
Biomarkers in Motor Neuron Disease: A State of the Art Review
Verber, N. S., Shepheard, S. R., Sassani, M., McDonough, H. E., Moore, S. A., Alix, J. J. P., Wilkinson, I. D., Jenkins, T. M., & Shaw, P. J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00291 · Cited by 130
Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier
Russ, J., Liu, E. Y., Wu, K., Neal, D., Suh, E. R., Irwin, D. J., McMillan, C. T., Harms, M. B., Cairns, N. J., Wood, E. M., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1365-0 · Cited by 127
Self-citation
The DNA Methylation in Neurological Diseases
Younesian, S., Yousefi, A., Momeny, M., Ghaffari, S. H., & Bashash, D. (2022) · Cells · doi:10.3390/cells11213439 · Cited by 141
C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels
Beckers, J., Tharkeshwar, A. K., & Damme, P. V. (2021) · Autophagy · doi:10.1080/15548627.2021.1872189 · Cited by 132
Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72
van Blitterswijk, M., Gendron, T. F., Baker, M., DeJesus‐Hernandez, M., Finch, N. A., Brown, P. H., Daughrity, L. M., Murray, M. E., Heckman, M. G., Jiang, J., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1480-6 · Cited by 127
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia
Benussi, A., Padovani, A., & Borroni, B. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00171 · Cited by 129
Disease Mechanisms ofC9ORF72Repeat ExpansionsPreprint
Gendron, T. F., & Petrucelli, L. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024224 · Cited by 106
Blood DNA methylation as a potential biomarker of dementia: A systematic review
Fransquet, P. D., Lacaze, P., Saffery, R., McNeil, J., Woods, R., & Ryan, J. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.10.002 · Cited by 96
In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers
DeJesus‐Hernandez, M., Finch, N. A., Wang, X., Gendron, T. F., Bieniek, K. F., Heckman, M. G., Vasilevich, A. S., Murray, M. E., Rousseau, L., Weesner, R. E., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1725-7 · Cited by 94
A C9orf72–CARM1 axis regulates lipid metabolism under glucose starvation-induced nutrient stressPreprint
Liu, Y., Wang, T., Ji, Y. J., Johnson, K., Liu, H., Johnson, K., Bailey, S., Suk, Y., Lu, Y., Liu, M., et al. (2018) · Genes & Development · doi:10.1101/gad.315564.118 · Cited by 84
Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism
Conlon, E. G., Fagegaltier, D., Agius, P., Davis‐Porada, J., Gregory, J. A., Hubbard, I., Kang, K., Kim, D., Phatnani, H. P., Kwan, J. Y., et al. (2018) · eLife · doi:10.7554/elife.37754 · Cited by 86
Self-citation
C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies
Vatsavayai, S. C., Nana, A. L., Yokoyama, J. S., & Seeley, W. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1921-0 · Cited by 82
Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM
Loveland, A. B., Svidritskiy, E., Susorov, D. S., Lee, S., Park, A., Zvornicanin, S. N., Demo, G., Gao, F., & Korostelev, A. A. (2022) · Nature Communications · doi:10.1038/s41467-022-30418-0 · Cited by 86
Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP‐43 pathology and not associated with aggregated forms of dipeptide repeat proteins
Davidson, Y., Robinson, A. C., Liu, X., Wu, D., Troakes, C., Rollinson, S., Masuda‐Suzukake, M., Suzuki, G., Nonaka, T., Shi, J., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12292 · Cited by 77
Mitochondrial DNA Copy Number and D-Loop Region Methylation in Carriers of Amyotrophic Lateral Sclerosis Gene Mutations
Stoccoro, A., Mosca, L., Carnicelli, V., Cavallari, U., Lunetta, C., Marocchi, A., Migliore, L., & Coppedè, F. (2018) · Epigenomics · doi:10.2217/epi-2018-0072 · Cited by 80
Solution structure of a DNA quadruplex containing ALS and FTD related GGGGCC repeat stabilized by 8-bromodeoxyguanosine substitution
Brčić, J., & Plavec, J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv815 · Cited by 76
Opening up the DNA methylome of dementia
Delgado‐Morales, R., & Esteller, M. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.242 · Cited by 74
Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration
Suh, E. R., Lee, E. B., Neal, D., Wood, E. M., Toledo, J. B., Rennert, L., Irwin, D. J., McMillan, C. T., Krock, B. L., Elman, L. B., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1445-9 · Cited by 72
Self-citation
Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair
Ababneh, N. A., Scaber, J., Flynn, R., Douglas, A. G. L., Barbagallo, P., Candalija, A., Turner, M. R., Sims, D., Dafinca, R., Cowley, S. A., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa106 · Cited by 76
Insights into the pathogenic mechanisms of chromosome 9 open reading frame 72 (C9orf72) repeat expansions
Todd, T. W., & Petrucelli, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13623 · Cited by 73
C9orf72 promoter hypermethylation is neuroprotective
McMillan, C. T., Russ, J., Wood, E. M., Irwin, D. J., Grossman, M., McCluskey, L. F., Elman, L. B., Deerlin, V. M. V., & Lee, E. B. (2015) · Neurology · doi:10.1212/wnl.0000000000001495 · Cited by 71
Self-citation
C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia
Mizielinska, S., & Isaacs, A. M. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000130 · Cited by 73
Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion
Leko, M. B., Župunski, V., Kirincich, J., Smilović, D., Hortobágyi, T., Hof, P. R., & Šimić, G. (2019) · Behavioural Neurology · doi:10.1155/2019/2909168 · Cited by 73
ALS and FTD: an epigenetic perspective
Belzil, V., Katzman, R. B., & Petrucelli, L. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1587-4 · Cited by 71
C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?
Braems, E., Swinnen, B., & Bosch, L. V. D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02214-x · Cited by 72
Quadruplex formation by both G-rich and C-rich DNA strands of theC9orf72(GGGGCC)8•(GGCCCC)8 repeat: effect of CpG methylation
Zamiri, B., Mirceta, M., Bomsztyk, K., Macgregor, R. B., & Pearson, C. E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1008 · Cited by 69
DNA methylation age-acceleration is associated with disease duration and age at onset in C9orf72 patients
Zhang, M., Tartaglia, M. C., Moreno, D., Sato, C., McKeever, P. M., Weichert, A., Keith, J. L., Robertson, J., Zinman, L. H., & Rogaeva, E. A. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1713-y · Cited by 65
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy
Cali, C. P., Patiño, M., Tai, Y. K., Ho, W. Y., McLean, C., Morris, C. M., Seeley, W. W., Miller, B. L., Gaig, C., Vonsattel, J. P., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02045-5 · Cited by 64
Self-citation
Genetic models of C9orf72: what is toxic?
Moens, T. G., Partridge, L., & Isaacs, A. M. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.01.006 · Cited by 57
R-Loops in Motor Neuron Diseases
Perego, M. G. L., Taiana, M. M., Bresolin, N., Comi, G. P., & Corti, S. P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1246-y · Cited by 60
Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-nuclear Transcripts in ALS and FTD Patients
Martier, R., Liefhebber, J. M. P., Miniarikova, J., van der Zon, T., Snapper, J., Kolder, I. C. R. M., Petry, H., van Deventer, S. J. H., Evers, M. M., & Konstantinova, P. S. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.01.010 · Cited by 59
C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease
Amick, J., & Ferguson, S. M. (2017) · Traffic · doi:10.1111/tra.12477 · Cited by 58
NMR structure of a G-quadruplex formed by four d(G4C2) repeats: insights into structural polymorphism
Brčić, J., & Plavec, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky886 · Cited by 55
The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis
Cooper‐Knock, J., Kirby, J., Highley, J. R., & Shaw, P. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0342-1 · Cited by 58
Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers
Dickson, D. W., Baker, M., Jackson, J. L., DeJesus‐Hernandez, M., Finch, N. A., Tian, S., Heckman, M. G., Pottier, C. P., Gendron, T. F., Murray, M. E., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0797-0 · Cited by 54
Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers
Jackson, J. L., Finch, N. A., Baker, M., Kachergus, J. M., DeJesus‐Hernandez, M., Pereira, K. L., Christopher, E. A., Prudencio, M., Heckman, M. G., Thompson, E. A., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0359-8 · Cited by 51
Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression
Tarr, I. S., McCann, E. P., Benyamin, B., Peters, T. J., Twine, N. A., Zhang, K. Y., Zhao, Q., Zhang, Z. H., Rowe, D. B., Nicholson, G. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44765-4 · Cited by 49
Roles of physical exercise in neurodegeneration: reversal of epigenetic clock
Xu, M., Zhu, J., Liu, X.-D., Luo, M.-Y., & Xu, N.-J. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00254-1 · Cited by 46
Evidence for nucleolar dysfunction in Alzheimer’s disease
Nyhus, C., Pihl, M., Hyttel, P., & Hall, V. J. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0104 · Cited by 44
RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders
Wojciechowska, M., Olejniczak, M., Galka-Marciniak, P., Jazurek, M., & Krzyżosiak, W. J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku794 · Cited by 45
Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansions
Cleary, E. M., Pal, S., Azam, T., Moore, D., Swingler, R. J., Gorrie, G., Stephenson, L. J., Colville, S., Chandran, S., Porteous, M. E., et al. (2016) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2016.06.001 · Cited by 46
Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis
Jimenez‐Pacheco, A., Franco, J. M., Lopez, S., Gómez‐Zumaquero, J. M., Leal‐Lasarte, M., Caballero-Hernández, D. E., Cejudo‐Guillén, M., & Pozo, D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_14 · Cited by 46
Endoplasmic Reticulum Stress: Implications for Neuropsychiatric Disorders
Muneer, A., & Khan, R. M. S. (2019) · Chonnam medical journal · doi:10.4068/cmj.2019.55.1.8 · Cited by 39
C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
Xiao, S., MacNair, L., McLean, J. R., McGoldrick, P., McKeever, P. M., Soleimani, S., Keith, J. L., Zinman, L. H., Rogaeva, E. A., & Robertson, J. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.062 · Cited by 48
Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C 9 ORF 72 hexanucleotide repeat expansion: a systematic neuropathological review
Schipper, L. J., Raaphorst, J., Aronica, E., Baas, F., de Haan, R. J., de Visser, M., & Troost, D. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12284 · Cited by 51
Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene
Wen, X., Westergard, T., Pasinelli, P., & Trotti, D. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.09.007 · Cited by 45
Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
Taskesen, E., Mishra, A., van der Sluis, S., Ferrari, R., Hernandez, D. G., Nalls, M. A., Rohrer, J. D., Ramasamy, A., Kwok, J. B., Dobson‐Stone, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09320-z · Cited by 41
eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS
Goodman, L. D., Prudencio, M., Srinivasan, A. R., Rifai, O. M., Lee, V. M. ‐., Petrucelli, L., & Bonini, N. M. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0711-9 · Cited by 46
The Genetics of C9orf72 ExpansionsPreprint
Gijselinck, I., Cruts, M., & Broeckhoven, C. V. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026757 · Cited by 43
Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia
Jiang, J., & Ravits, J. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00797-2 · Cited by 44
RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis
Chan, H. Y. E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00431 · Cited by 39
Conserved DNA methylation combined with differential frontal cortex and cerebellar expression distinguishes C9orf72-associated and sporadic ALS, and implicates SERPINA1 in disease
Ebbert, M., Ross, C. A., Pregent, L., Lank, R. J., Zhang, C., Katzman, R. B., Jansen‐West, K. R., Song, Y., da Rocha, E. L., Palmucci, C., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1760-4 · Cited by 43
Unstable repeat expansions in neurodegenerative diseases: nucleocytoplasmic transport emerges on the scene
Loureiro, J. R., Oliveira, C. L., & Silveira, I. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.007 · Cited by 38
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Esanov, R., Cabrera, G. T., Andrade, N. S., Gendron, T. F., Brown, R. H., Benatar, M. G., Wahlestedt, C., Mueller, C., & Zeier, Z. R. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0185-9 · Cited by 35
Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice
Jury, N., Abarzúa, S., Díaz, I. D. P., Guerra, M. V., Ampuero, E., Cubillos, P., Martínez, P., Herrera-Soto, A., Arredondo, C., Rojas, F., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-0816-9 · Cited by 35
Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G4C2)n expression in C9orf72 ALS/FTD
Czuppa, M., Dhingra, A., Zhou, Q., Schludi, C., König, L. E., Scharf, E., Farny, D., Dalmia, A., Täger, J., Castillo-Lizardo, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110913 · Cited by 29
Molecular hallmarks of ageing in amyotrophic lateral sclerosis
Jagaraj, C. J., Shadfar, S., Kashani, S. A., Saravanabavan, S., Farzana, F., & Atkin, J. D. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05164-9 · Cited by 39
Bromodomain inhibitors regulate the C9ORF72 locus in ALS
Zeier, Z. R., Esanov, R., Belle, K. C., Volmar, C., Johnstone, A. L., Halley, P., DeRosa, B. A., Khoury, N., van Blitterswijk, M., Rademakers, R., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.06.017 · Cited by 33
RNA FISH for detecting expanded repeats in human diseases
Urbanek-Trzeciak, M. O., & Krzyżosiak, W. J. (2015) · Methods · doi:10.1016/j.ymeth.2015.11.017 · Cited by 32
A concise review of human brain methylome during aging and neurodegenerative diseases
Prasad G, R., & Jho, E.-H. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.10.215 · Cited by 31
Uncovering the Role of the Methylome in Dementia and Neurodegeneration
Klein, H., & Jager, P. L. D. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.06.008 · Cited by 31
Emerging role of RNA•DNA hybrids inC9orf72-linked neurodegeneration
Wang, J., Haeusler, A. R., & Simko, E. A. J. (2015) · Cell Cycle · doi:10.1080/15384101.2014.995490 · Cited by 31
Targeted DNA methylation of neurodegenerative disease genes via homology directed repair
Cali, C. P., Park, D. S., & Lee, E. B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz979 · Cited by 28
Self-citation
Methylation of C9orf72 expansion reduces RNA foci formation and dipeptide-repeat proteins expression in cells
Bauer, P. O. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.018 · Cited by 28
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells
Esanov, R., Belle, K. C., van Blitterswijk, M., Belzil, V., Rademakers, R., Dickson, D. W., Petrucelli, L., Boylan, K., Dykxhoorn, D. M., Wuu, J., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.12.022 · Cited by 28
Aberrant Phase Separation is a Common Killing Strategy of Positively Charged Peptides in Biology and Human DiseasePreprint
Boeynaems, S., Ma, X. R., Yeong, V., Ginell, G. M., Chen, J.-H., Blum, J. A., Nakayama, L., Sanyal, A., Briner, A., Haver, D. V., et al. (2023) · SSRN Electronic Journal · doi:10.1101/2023.03.09.531820 · Cited by 24
DNA-initiated epigenetic cascades driven by C9orf72 hexanucleotide repeat
Liu, Y., Huang, Z., Liu, H., Ji, Z., Arora, A., Cai, D., Wang, H., Liu, M., Simko, E. A. J., Zhang, Y., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.022 · Cited by 22
Ablation of C9orf72 together with excitotoxicity induces ALS in rats
Dong, W., Ma, Y., Guan, F., Zhang, X., Chen, W., Zhang, L., & Zhang, L. (2020) · FEBS Journal · doi:10.1111/febs.15501 · Cited by 25
From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis
Alrafiah, A. (2018) · In Vivo · doi:10.21873/invivo.11339 · Cited by 28
Screening for rare epigenetic variations in autism and schizophrenia
Garg, P., & Sharp, A. J. (2019) · Human Mutation · doi:10.1002/humu.23740 · Cited by 20
Marked Differences in C9orf72 Methylation Status and Isoform Expression between C9/ALS Human Embryonic and Induced Pluripotent Stem Cells
Cohen‐Hadad, Y., Altarescu, G., Eldar‐Geva, T., Levy‐Lahad, E., Zhang, M., Rogaeva, E. A., Gotkine, M., Bartok, O., Ashwal-Fluss, R., Kadener, S., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.09.011 · Cited by 24
C9orf72/ALFA-1 controls TFEB/HLH-30-dependent metabolism through dynamic regulation of Rag GTPases
Ji, Y. J., Ugolino, J., Zhang, T., Lu, J., Kim, D., & Wang, J. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008738 · Cited by 22

Authors: Liu, E. Y., Russ, J., Wu, K., Neal, D., Suh, E., McNally, A. G., Irwin, D. J., Van Deerlin, V. M., & Lee, E. B.
Affiliations: University of Pennsylvania (US)
Corresponding author: Lee, Edward B.
ORCID: Russ, Jenny
Wu, Kathryn
Suh, Eunran
McNally, Anna G.
Irwin, David J.
Lee, Edward B.
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2014-05-08
Volume: 128
Issue: 4
Pages: 525-541
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-014-1286-y
PMC: PMC4161616
OpenAlex: W1982725145
Cited by: 180
References: 68
Citations by year: 2026: 4 · 2025: 10 · 2024: 9 · 2023: 7 · 2022: 6 · 2021: 17 · 2020: 15 · 2019: 17 · 2018: 19 · 2017: 20 · 2016: 19 · 2015: 30 · 2014: 7
FWCI: 16.52
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Centers for Disease Control and Prevention (ND14442, ND11836, ND16183, ND10966)
National Institute on Aging (P30AG10125, T32 AG 00255, P30AG010124, P01AG017586, K08AG039510, P01AG032953, T32AG000255)
National Institute of Neurological Disorders and Stroke (K23NS088341)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords: C9orf72, hexanucleotide repeat expansion, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, CpG hypermethylation, promoter hypermethylation, epigenetic silencing, RNA foci, oxidative stress
MeSH terms: C9orf72 Protein, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Analysis of Variance, Cell Line, Transformed, DNA Mutational Analysis, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Mutation, Promoter Regions, Genetic, Proteins, RNA, Messenger, CpG Islands, DNA Methylation, DNA Repeat Expansion, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks